Preclinical Evaluation of Nintedanib, a Triple Angiokinase Inhibitor, in Soft-tissue Sarcoma: Potential Therapeutic Implication for Synovial Sarcoma
Crossref DOI link: https://doi.org/10.1158/1535-7163.MCT-18-0319
Published Online: 2018-11-02
Published Print: 2018-11-01
Update policy: https://doi.org/10.1158/crossmark_policy
Patwardhan, Parag P.
Musi, Elgilda
Schwartz, Gary K.
Funding for this research was provided by:
Columbia University